← Back to Knowledge Portal

Knowledge Portal

Cirrhosis and non-hepatic surgery

Patients with cirrhosis undergoing non-hepatic surgery have an increased risk of postoperative decompensation, infection, bleeding, acute kidney injury and death. Risk is determined by both liver disease severity and the physiological burden and urgency of surgery. Assessment should therefore combine the current clinical state, portal-hypertension phenotype, frailty and comorbidity with a validated surgical risk tool such as VOCAL-Penn rather than relying on Child-Pugh or MELD alone. Elective surgery provides an opportunity to treat active decompensation, optimise nutrition and volume status, review alcohol use and medications, and involve hepatology, anaesthesia and critical care early. Postoperative surveillance should focus on new ascites, encephalopathy, infection, AKI, bleeding and haemodynamic deterioration, with a low threshold for higher-acuity monitoring in patients at increased risk.

Curated guidance and resourcesReviewed 22 Aug 2026

Key information

Guidelines and position statements

Relevant clinical practice guidelines, practice guidance, consensus statements and position papers from professional bodies and expert groups.

Further context

Other useful resources

Selected review articles, practical explainers, expert discussions, reference sites and e-learning from established providers.

FreeExternal resource ↗

VOCAL-Penn Cirrhosis Surgical Risk Score

Penn Medicine · validated perioperative risk calculator

Estimates 30-, 90- and 180-day postoperative mortality using liver-related variables, comorbidity, surgery category and urgency. Use as part of multidisciplinary assessment rather than as a stand-alone decision rule.

Open resource →